These five sites are in various stages of redevelopment. The wrecking ball is swinging on two sites, home construction is ...

Gov. Hohcul announced part of Saint Rose campus will be turned into a workforce development hub as part of the ON RAMP initiative ...

Inside Look is a Fresno Bee series where we take readers behind the scenes at restaurants, new businesses, local landmarks and news stories. For about a year, Fresnans have been curiously eyeing the ...

The Center for Economic Growth will lead the project. The state will offer up to $300,000 for the center to develop a ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Investing.com - US stock futures were trading in negative territory during Sunday's evening deals, following a mixed week for benchmark averages amid mixed inflation data and major financial ...

Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities ...

The massing of the housing blocks is opened up by slate roofs whose pitches alternate in direction. The buildings get lower in height as they approach the River Clyde almost as a gesture of respect.

This meticulously recreated map of the city built entirely in Minecraft includes buildings, streets, parks, and more, all taken directly from a real-life map view of the city at a 1:1 scale ...

As the demand for built environment grows, the inevitable question becomes do we knock down existing buildings in order to make way for new developments, or try wherever possible to utilise ...

Trevogrumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success ...